A retrospective cohort study has reported that a withdrawal syndrome is common in PD patients who discontinue treatment with a dopamine agonist (Rabinak & Nirenberg. Arch Neurol 2010; 67: 58-63).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
